Keywords: abbott, says, phase, iii, d2e7, data, back

Abbott says Phase III D2E7 data back up safety profile of the antibody

Article | 24 June 2002

Print This

Phase III data from the STAR trial, reported at the European LeagueAgainst Rheumatism meeting in Stockholm, Sweden, have confirmed the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in